Literature DB >> 9491024

Early detection of developmental dysplasia of the hip in The Netherlands: the validity of a standardized assessment protocol in infants.

M M Boere-Boonekamp1, T H Kerkhoff, P B Schuil, G A Zielhuis.   

Abstract

OBJECTIVES: This study evaluated the validity of the traditionally recommended screening protocol for developmental dysplasia of the hip in infants.
METHODS: Study children (n = 1968) underwent a standardized screening examination.
RESULTS: The incidence of developmental dysplasia of the hip was 3.7%. The sensitivity of the test protocol was 86%, the specificity was 82%, and the predictive values of positive and negative tests were 16% and 99%, respectively.
CONCLUSIONS: The validity of the screening protocol for developmental dysplasia of the hip is disappointingly low. The yield of adding an ultrasonographic examination to current screening activities needs further study.

Entities:  

Mesh:

Year:  1998        PMID: 9491024      PMCID: PMC1508179          DOI: 10.2105/ajph.88.2.285

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  10 in total

1.  [Early diagnosis of hip dysplasia--arguments for a general ultrasonographic screening].

Authors:  R A Bon; G U Exner
Journal:  Schweiz Rundsch Med Prax       Date:  1992-04-14

2.  [Ultrasonography as initial imaging study can replace roentgen studies under certain circumstances in suspected congenital hip dysplasia].

Authors:  R J de Raadt; A F Diepstraten; M Meradji; S F Robben
Journal:  Ned Tijdschr Geneeskd       Date:  1992-05-16

3.  Developmental dislocation of the hip: evolutionary changes in diagnosis and treatment.

Authors:  S S Coleman
Journal:  J Pediatr Orthop       Date:  1994 Jan-Feb       Impact factor: 2.324

4.  Ultrasound screening for developmental dysplasia of the hip in the neonate: the effect on treatment rate and prevalence of late cases.

Authors:  K Rosendahl; T Markestad; R T Lie
Journal:  Pediatrics       Date:  1994-07       Impact factor: 7.124

5.  Developmental dysplasia of the hip.

Authors:  D D Aronsson; M J Goldberg; T F Kling; D R Roy
Journal:  Pediatrics       Date:  1994-08       Impact factor: 7.124

6.  Congenital dislocation of the hip: early and late diagnosis and management compared.

Authors:  P M Dunn; R E Evans; M J Thearle; H E Griffiths; P J Witherow
Journal:  Arch Dis Child       Date:  1985-05       Impact factor: 3.791

7.  Prevention of congenital dislocation of the hip. The Swedish experience of neonatal treatment of hip joint instability.

Authors:  K Palmén
Journal:  Acta Orthop Scand Suppl       Date:  1984

8.  Ultrasound imaging and secondary screening for congenital dislocation of the hip.

Authors:  N R Boeree; N M Clarke
Journal:  J Bone Joint Surg Br       Date:  1994-07

9.  Cost-effectiveness of alternative screening strategies for developmental dysplasia of the hip.

Authors:  K Rosendahl; T Markestad; R T Lie; E Sudmann; J T Geitung
Journal:  Arch Pediatr Adolesc Med       Date:  1995-06

10.  Congenital hip dislocation: an increasing and still uncontrolled disability?

Authors:  J C Catford; G C Bennet; J A Wilkinson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-27
  10 in total
  11 in total

Review 1.  Preventive health care, 2001 update: screening and management of developmental dysplasia of the hip in newborns.

Authors:  H Patel
Journal:  CMAJ       Date:  2001-06-12       Impact factor: 8.262

2.  Effectiveness of ultrasound screening for developmental dysplasia of the hip.

Authors:  E A Roovers; M M Boere-Boonekamp; R M Castelein; G A Zielhuis; T H Kerkhoff
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

3.  Patient follow up screening evaluations. Examples with regard to congenital hip dislocation and congenital heart disease.

Authors:  R E Juttmann; J Hess; G J van Oortmarssen ; P J van der Maas
Journal:  J Epidemiol Community Health       Date:  2001-02       Impact factor: 3.710

4.  The Rotterdam AMblyopia Screening Effectiveness Study (RAMSES): compliance and predictive value in the first 2 years.

Authors:  R Juttmann
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

Review 5.  Treatment of centered developmental dysplasia of the hip under the age of 1 year: an evidence-based clinical practice guideline - Part 1.

Authors:  Christiaan J A van Bergen; Pieter Bas de Witte; Floor Willeboordse; Babette L de Geest; Magritha Margret M H P Foreman-van Drongelen; Bart J Burger; Yvon M den Hartog; Joost H van Linge; Renske M Pereboom; Simon G F Robben; M Adhiambo Witlox; Melinda M E H Witbreuk
Journal:  EFORT Open Rev       Date:  2022-07-05

6.  Implementation by simulation; strategies for ultrasound screening for hip dysplasia in the Netherlands.

Authors:  Sabrina Ramwadhdoebe; Godefridus G Van Merode; Magda M Boere-Boonekamp; Ralph J B Sakkers; Erik Buskens
Journal:  BMC Health Serv Res       Date:  2010-03-23       Impact factor: 2.655

7.  Can a triple pelvic osteotomy for adult symptomatic hip dysplasia provide relief of symptoms for 25 years?

Authors:  Renee Anne van Stralen; Gijs G van Hellemondt; Navin N Ramrattan; Enrico de Visser; Marinus de Kleuver
Journal:  Clin Orthop Relat Res       Date:  2012-11-21       Impact factor: 4.176

8.  Diagnosis and treatment of developmental dysplasia of the hip in the Netherlands: national questionnaire of paediatric orthopaedic surgeons on current practice in children less than 1 year old.

Authors:  Rick H M Heeres; M M E H Witbreuk; J A van der Sluijs
Journal:  J Child Orthop       Date:  2011-07-03       Impact factor: 1.548

9.  Feasibility and Impact of Doctor-Nurse Task Delegation in Preventive Child Health Care in the Netherlands, a Controlled Before-After Study.

Authors:  S Janine Benjamins; Maurice L W Damen; Henk F van Stel
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

Review 10.  Symptomatic asymmetry in the first six months of life: differential diagnosis.

Authors:  Jacqueline Nuysink; Ingrid C van Haastert; Tim Takken; Paul J M Helders
Journal:  Eur J Pediatr       Date:  2008-03-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.